During the past decade, Staedtisches Krankenhaus Muenchen - Harlaching conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Staedtisches Krankenhaus Muenchen - Harlaching" #1 sponsor was "German CLL Study Group" with 3 trials, followed by "Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany" with 3 trials sponsored, "Universitätsklinikum Hamburg-Eppendorf" with 2 trials sponsored, "Agennix" with 1 trials sponsored and "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Staedtisches Krankenhaus Muenchen - Harlaching" #1 collaborator was "German CLL Study Group" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Staedtisches Krankenhaus Muenchen - Harlaching" are "Leukemia" (5 trials), "Chronic Lymphocytic Leukemia" (3 trials), "Neuroblastoma" (2 trials), "Brain and Central Nervous System Tumors" (1 trials) and "Long-term Effects Secondary to Cancer Therapy in Children" (1 trials). Many other conditions were trialed in "Staedtisches Krankenhaus Muenchen - Harlaching" in a lesser frequency.

Most popular intervention types in "Staedtisches Krankenhaus Muenchen - Harlaching" are "Drug" (13 trials), "Radiation" (9 trials), "Biological" (5 trials), "Procedure" (5 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (7 trials), "cyclophosphamide" (6 trials), "doxorubicin hydrochloride" (4 trials), "filgrastim" (4 trials) and "peripheral blood stem cell transplantation" (4 trials). Other intervention names were less common.

The vast majority of trials in "Staedtisches Krankenhaus Muenchen - Harlaching" are 13 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Staedtisches Krankenhaus Muenchen - Harlaching". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Staedtisches Krankenhaus Muenchen - Harlaching, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Staedtisches Krankenhaus Muenchen - Harlaching, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".